Literature DB >> 23630946

Progression of glomerular filtration rate reduction determined in conscious Dahl salt-sensitive hypertensive rats.

Allen W Cowley1, Robert P Ryan, Terry Kurth, Meredith M Skelton, Daniel Schock-Kusch, Norbert Gretz.   

Abstract

Sequential changes in glomerular filtration rate during development of hypertension in the conscious Dahl salt-sensitive rats were determined using a new method for measurement. Using a miniaturized device, disappearance curves of fluorescein isothiocyanate-sinistrin were measured by transcutaneous excitation and real-time detection of the emitted light through the skin. Rats with implanted femoral venous catheters (dye injection and sampling) and carotid catheters (mean arterial pressure by telemetry) were studied, while maintained on a 0.4% NaCl diet and on days 2, 5, 7, 14, and 21 after switching to 4.0% (high-salt [HS]) diet. A separate group of rats were maintained on 0.4% for 21 days as a time control. Mean arterial pressure rose progressively from the last day of 0.4% (130±2 mm Hg) reaching significance by day 5 of HS and averaged 162±7 mm Hg by day 21. Urine albumin excretion was significantly elevated (×3) by day 7 of HS in Dahl salt-sensitive rats. Glomerular filtration rate reduced on day 14 of HS falling from 1.53±0.06 mL/min per 100 g body weight to 1.27±0.04. By day 21, glomerular filtration rate had fallen 28% to 1.1±0.04 mL/min per 100 g (t(1/2) 28.4±1.1 minute.) No significant reductions of creatinine clearance were observed throughout the study in response to HS demonstrating the insensitivity of creatinine clearance measurements even with creatinine measured using mass spectrometry. We conclude that the observed reduction of glomerular filtration rate was a consequence and not a cause of the hypertension and that this noninvasive approach could be used in these conscious Dahl salt-sensitive rats for a longitudinal assessment of renal function.

Entities:  

Keywords:  Dahl SS rat; GFR; creatinine clearance; salt-sensitive hypertension

Mesh:

Substances:

Year:  2013        PMID: 23630946      PMCID: PMC3806646          DOI: 10.1161/HYPERTENSIONAHA.113.01194

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  36 in total

1.  Practicability of the inulin plasma single-shot clearance.

Authors:  N Gretz; K H Ecker-Tschirner; H F Kühnle; K von Dahl; M Kirschfink; P Drescher; J J Lasserre; M Strauch
Journal:  Contrib Nephrol       Date:  1990       Impact factor: 1.580

2.  Influence of three anesthetic protocols on glomerular filtration rate in dogs.

Authors:  Marion Fusellier; Jean-Claude Desfontis; Stéphane Madec; Freddy Gautier; Michelle Debailleul; Marc Gogny
Journal:  Am J Vet Res       Date:  2007-08       Impact factor: 1.156

3.  Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements.

Authors:  Johannes Pill; Oxana Issaeva; Stefanie Woderer; Maliha Sadick; Bettina Kränzlin; Fritz Fiedler; Hans-Martin Klötzer; Uwe Krämer; Norbert Gretz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-12       Impact factor: 3.000

4.  Prevention with thiazide of NaCl-induced hypertension in Dahl "S" rats. Evidence for a Na-retaining humoral agent in "S" rats.

Authors:  L Tobian; J Lange; J Iwai; K Hiller; M A Johnson; P Goossens
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

5.  Salt and hypertension.

Authors:  L K Dahl
Journal:  Am J Clin Nutr       Date:  1972-02       Impact factor: 7.045

6.  TGF and nitric oxide: effects of salt intake and salt-sensitive hypertension.

Authors:  C S Wilcox; W J Welch
Journal:  Kidney Int Suppl       Date:  1996-06       Impact factor: 10.545

7.  Renal handling of drugs in the healthy elderly. Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged.

Authors:  D Fliser; I Bischoff; A Hanses; S Block; M Joest; E Ritz; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1999-05       Impact factor: 2.953

8.  Fluorescein-labeled sinistrin as marker of glomerular filtration rate.

Authors:  Johannes Pill; Bettina Kraenzlin; Julia Jander; Tim Sattelkau; Maliha Sadick; Hans-Martin Kloetzer; Carsten Deus; Uwe Kraemer; Norbert Gretz
Journal:  Eur J Med Chem       Date:  2005-10       Impact factor: 6.514

9.  Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay.

Authors:  A Keppler; N Gretz; R Schmidt; H-M Kloetzer; H-J Groene; B Lelongt; M Meyer; M Sadick; J Pill
Journal:  Kidney Int       Date:  2006-11-01       Impact factor: 10.612

10.  Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats.

Authors:  R J Roman
Journal:  Am J Physiol       Date:  1986-07
View more
  35 in total

1.  Intravital imaging of the kidney in a rat model of salt-sensitive hypertension.

Authors:  Bradley T Endres; Ruben M Sandoval; George J Rhodes; Silvia B Campos-Bilderback; Malgorzata M Kamocka; Christopher McDermott-Roe; Alexander Staruschenko; Bruce A Molitoris; Aron M Geurts; Oleg Palygin
Journal:  Am J Physiol Renal Physiol       Date:  2017-04-12

Review 2.  Why and how we determine nephron number.

Authors:  John F Bertram; Luise A Cullen-McEwen; Gary F Egan; Norbert Gretz; Edwin Baldelomar; Scott C Beeman; Kevin M Bennett
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

Review 3.  Complications during pregnancy and fetal development: implications for the occurrence of chronic kidney disease.

Authors:  Ashley D Newsome; Gwendolyn K Davis; Norma B Ojeda; Barbara T Alexander
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-02-16

4.  A kidney-selective biopolymer for targeted drug delivery.

Authors:  Gene L Bidwell; Fakhri Mahdi; Qingmei Shao; Omar C Logue; Jamarius P Waller; Caleb Reese; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-26

5.  Black-White Difference in the Impact of Long-Term Blood Pressure From Childhood on Adult Renal Function: The Bogalusa Heart Study.

Authors:  Yinkun Yan; Tao Zhang; Shengxu Li; Yang Liu; Lydia Bazzano; Jiang He; Jie Mi; Wei Chen
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

6.  Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy.

Authors:  Zhi Su; Deborah Widomski; Ji Ma; Marian Namovic; Arthur Nikkel; Laura Leys; Lauren Olson; Katherine Salte; Diana Donnelly-Roberts; Timothy Esbenshade; Steve McGaraughty
Journal:  Am J Nephrol       Date:  2016-10-14       Impact factor: 3.754

7.  Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Ashley C Johnson; Lateia Taylor; Cassandra Stubbs; Alyssa Nichols; Denise C Cornelius; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

8.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

9.  Null mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration rate.

Authors:  Louise C Evans; Robert P Ryan; Elizabeth Broadway; Meredith M Skelton; Theresa Kurth; Allen W Cowley
Journal:  Hypertension       Date:  2014-12-08       Impact factor: 10.190

10.  The role of adenosine 1a receptor signaling on GFR early after the induction of sepsis.

Authors:  Jonathan M Street; Erik H Koritzinsky; Tiffany R Bellomo; Xuzhen Hu; Peter S T Yuen; Robert A Star
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.